从缺乏内源性免疫球蛋白谱的转基因"LamaMice"产生纳米体
Thomas Eden1, Alessa Z Schaffrath1, Janusz Wesolowski1
1Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Nature communications
|June 3, 2024
概括
研究人员开发了LamaMice,这是一个转基因小鼠模型,用于高效地产生拉玛纳米体. 这个平台简化了这些有价值的生物工具的生产,克服了传统的基于拉玛的方法的局限性.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 纳米体具有优良的溶解性和稳定性,使它们对研究和治疗有价值.
- 传统的纳米体生成在拉玛是复杂和昂贵的.
研究的目的:
- 创建一个新的转基因小鼠模型,用于简化纳米体的生产.
- 建立一个灵活的平台,用于生成特定目标的纳米体.
主要方法:
- 设计了一种驼免疫球蛋白重链 (IgH) 位点,并将其插入IgH缺乏的小鼠中,以创建"LamaMouse".
- 验证了LamaMice只表达拉玛IgH分子,没有Igκ或λ光链.
- 用各种抗原 (AAV8,SARS-CoV-2 RBD,IgE,IgG2c,CLEC9A) 免疫了LamaMice,并利用了多种选择技术.
主要成果:
- 使用LamaMice成功生成针对不同抗原的特定目标纳米体.
- 证明了混合瘤,菌体显示,单个B细胞查和直接谱系克隆的有效性.
- 在没有相关的小鼠光链的LamaMice中证实了拉玛IgH的表达.
结论:
- 拉玛鼠是一个多功能和有效的平台,用于简化纳米体的发现.
- 这个模型克服了与基于拉玛的纳米体生成相关的挑战.
- 促进开发基于纳米体的研究工具和治疗方法.
相关概念视频
Hybridoma Technology
14.6K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.6K
In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K


